patients that have an A1c of 8 or higher reduce it by 1% to 7!!
patients whose A1c is less than 8 reduce it by about .5, with no increase in hyperglycemic events - awsome!!
Insurance companies know how patients with high A1cs are much more costly in terms of complications, and will gladly pay for this device. Patients will buy it either way, because it is a proven A1c-lowering device.
if this stock gets cheaper - I'll buy more
(sorry for the interruption, I'll sit down now. Talk amongst yourselves...)